Viera Lukacova, Ph.D. - Publications

Affiliations: 
2002 North Dakota State University, Fargo, ND, United States 
Area:
Pharmacy, Pharmaceutical Chemistry

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Natesan S, Lukacova V, Peng M, Subramaniam R, Lynch S, Wang Z, Tandlich R, Balaz S. Structure-based prediction of drug distribution across the headgroup and core strata of a phospholipid bilayer using surrogate phases. Molecular Pharmaceutics. 11: 3577-95. PMID 25179490 DOI: 10.1021/Mp5003366  0.746
2013 Lukacova V, Natesan S, Peng M, Tandlich R, Wang Z, Lynch S, Subramaniam R, Balaz S. Structural determinants of drug partitioning in surrogates of phosphatidylcholine bilayer strata. Molecular Pharmaceutics. 10: 3684-96. PMID 23964749 DOI: 10.1021/Mp400204Y  0.764
2013 Natesan S, Wang Z, Lukacova V, Peng M, Subramaniam R, Lynch S, Balaz S. Structural determinants of drug partitioning in n-hexadecane/water system. Journal of Chemical Information and Modeling. 53: 1424-35. PMID 23641957 DOI: 10.1021/Ci400112K  0.696
2012 Natesan S, Wang T, Lukacova V, Bartus V, Khandelwal A, Subramaniam R, Balaz S. Cellular quantitative structure-activity relationship (Cell-QSAR): conceptual dissection of receptor binding and intracellular disposition in antifilarial activities of Selwood antimycins. Journal of Medicinal Chemistry. 55: 3699-712. PMID 22468611 DOI: 10.1021/Jm201371Y  0.728
2011 Natesan S, Wang T, Lukacova V, Bartus V, Khandelwal A, Balaz S. Rigorous treatment of multispecies multimode ligand-receptor interactions in 3D-QSAR: CoMFA analysis of thyroxine analogs binding to transthyretin. Journal of Chemical Information and Modeling. 51: 1132-50. PMID 21476521 DOI: 10.1021/Ci200055S  0.733
2008 Zhang Y, Lukacova V, Bartus V, Nie X, Sun G, Manivannan E, Ghorpade SR, Jin X, Manyem S, Sibi MP, Cook GR, Balaz S. Binding of matrix metalloproteinase inhibitors to extracellular matrix: 3D-QSAR analysis. Chemical Biology & Drug Design. 72: 237-48. PMID 18844670 DOI: 10.1111/J.1747-0285.2008.00710.X  0.711
2007 Zhang Y, Lukacova V, Bartus V, Balaz S. Structural determinants of binding of aromates to extracellular matrix: a multi-species multi-mode CoMFA study. Chemical Research in Toxicology. 20: 11-9. PMID 17226922 DOI: 10.1021/Tx060188L  0.738
2007 Lukacova V, Peng M, Fanucci G, Tandlich R, Hinderliter A, Maity B, Manivannan E, Cook GR, Balaz S. Drug-membrane interactions studied in phospholipid monolayers adsorbed on nonporous alkylated microspheres. Journal of Biomolecular Screening. 12: 186-202. PMID 17218665 DOI: 10.1177/1087057106297063  0.74
2006 Zhang Y, Lukacova V, Reindl K, Balaz S. Quantitative characterization of binding of small molecules to extracellular matrix. Journal of Biochemical and Biophysical Methods. 67: 107-22. PMID 16516301 DOI: 10.1016/J.Jbbm.2006.01.007  0.696
2006 Lukacova V, Peng M, Tandlich R, Hinderliter A, Balaz S. Partitioning of organic compounds in phases imitating the headgroup and core regions of phospholipid bilayers. Langmuir : the Acs Journal of Surfaces and Colloids. 22: 1869-74. PMID 16460120 DOI: 10.1021/La052187J  0.742
2005 Khandelwal A, Lukacova V, Kroll DM, Raha S, Comez D, Balaz S. Processing multimode binding situations in simulation-based prediction of ligand-macromolecule affinities. The Journal of Physical Chemistry. A. 109: 6387-91. PMID 16833982 DOI: 10.1021/Jp051105X  0.744
2005 Khandelwal A, Lukacova V, Comez D, Kroll DM, Raha S, Balaz S. A combination of docking, QM/MM methods, and MD simulation for binding affinity estimation of metalloprotein ligands. Journal of Medicinal Chemistry. 48: 5437-47. PMID 16107143 DOI: 10.1021/Jm049050V  0.751
2005 Lukacova V, Zhang Y, Kroll DM, Raha S, Comez D, Balaz S. A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity. Journal of Medicinal Chemistry. 48: 2361-70. PMID 15801829 DOI: 10.1021/Jm0491703  0.677
2004 Cook GR, Manivannan E, Underdahl T, Lukacova V, Zhang Y, Balaz S. Synthesis and evaluation of novel oxazoline MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 14: 4935-9. PMID 15341955 DOI: 10.1016/J.Bmcl.2004.07.023  0.633
2004 Lukacova V, Zhang Y, Mackov M, Baricic P, Raha S, Calvo JA, Balaz S. Similarity of binding sites of human matrix metalloproteinases. The Journal of Biological Chemistry. 279: 14194-200. PMID 14732707 DOI: 10.1074/Jbc.M313474200  0.681
2004 Khandelwal A, Lukacova V, Kroll DM, Çömez D, Raha S, Balaz S. Simulation-based predictions of binding affinities of matrix metalloproteinase inhibitors Qsar and Combinatorial Science. 23: 754-766. DOI: 10.1002/Qsar.200430896  0.763
2003 Lukacova V, Balaz S. Multimode ligand binding in receptor site modeling: implementation in CoMFA. Journal of Chemical Information and Computer Sciences. 43: 2093-105. PMID 14632461 DOI: 10.1021/Ci034100A  0.686
2002 Balaz S, Lukacova V. Subcellular pharmacokinetics and its potential for library focusing. Journal of Molecular Graphics & Modelling. 20: 479-90. PMID 12071282 DOI: 10.1016/S1093-3263(01)00149-8  0.676
1999 Baláž Š, Lukáčová V. A Model-based Dependence of the Human Tissue/Blood Partition Coefficients of Chemicals on Lipophilicity and Tissue Composition Quantitative Structure-Activity Relationships. 18: 361-368. DOI: 10.1002/(Sici)1521-3838(199910)18:4<361::Aid-Qsar361>3.0.Co;2-A  0.363
Show low-probability matches.